New Hampshire HB 513: relative to affordability and safety of clinician administered drugs.

Status: Interim Study Report: Not Recommended for Future Legislation (Vote 16-0) (as of 2024-10-31)

State: New Hampshire · Session: 2024 · Bill: HB 513

Sponsors: Tim S McGough

View New Hampshire HB 513 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.